$15.71 0.23 (+1.49%)
11/6/2009 4:00 PM

Regeneron Pharmaceuticals, Inc. (REGN)

CAPS Rating: 2 out of 5

The Company is a biopharmaceutical company that discovers, develops, and intends to commercialize pharmaceutical products for the treatment of serious medical conditions.

Current Price $15.71 Mkt Cap $1.26B
Open $15.36 P/E Ratio 0.00
Prev. Close $15.48 Div. (Yield) N/A (N/A)
Daily Range $15.36 - $15.73 Volume 356,862
52-Wk Range $11.81 - $23.49 Avg. Daily Vol. 590,000

REGN News and Commentary

Caps

How do you think REGN will perform vs the S&P 500?

Add Stock to Watchlist

All Members

95 Outperform
30 Underperform
 

All-Star Members

20 Outperform
18 Underperform
 

Wall Street

8 Outperform
1 Underperform
 

Top REGN Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

daviddai (62.85)
Submitted March 08, 2007

The stock has strong therapeutic candidates (interleukin-1 trap and VEGF trap) which, I believe, are likely be approved by FDA in the coming years. This will give them the profit margin that they so desperate need in order to expand their R&D for… More

0 Comments | Reply | Report this Post

kurthauer1998 (86.70)
Submitted January 21, 2008

The company's clinical development programs include Interleukin-1 (IL-1) Trap for various inflammatory indications, VEGF Trap for oncology, and VEGF Trap-Eye formulation for eye diseases. The IL-1 Trap is a protein-based product candidate designed to… More

0 Comments | Reply | Report this Post
REGN VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from members about REGN.

Recs

0
Member Avatar Julio60 (< 20) Submitted: 10/5/2009 3:31:29 PM : Outperform Start Price: $18.57 REGN Score: -18.26

bullish

Report this Post 0 Comments | Reply | Permalink

Recs

0
Member Avatar mjan706 (< 20) Submitted: 9/22/2008 1:44:10 AM : Outperform Start Price: $22.84 REGN Score: -19.44

An Icahn portfolio stock.

Report this Post 0 Comments | Reply | Permalink

Recs

0
Member Avatar CavalierGator (81.73) Submitted: 7/23/2008 5:26:15 PM : Outperform Start Price: $18.80 REGN Score: -2.57

The stock was incredibly oversold based on bad data from a phase II trial, especially given the trial's endpoint was ambitious enough that Avastin likely would also have missed it. I think the VEGF trap will still reach the market and the company will be profitable before the end of 2009.

Report this Post 0 Comments | Reply | Permalink
View All 14 Pitches »

Leaderboard

Find the members with the highest scoring picks in REGN.

Score Leader

robbg52999

robbg52999 (99.39) Score: +56.01

The Score Leader is the member with the highest score across all their picks in REGN.

Top
Pick 		Member Name Member
Rating 		Start
Date 		Call Time
Frame 		Start
Price 		Stock
Gain 		S&P
Gain 		Score Commentary
BetapegAnalytics 92.09 8/13/2009 Underperform 5Y $22.65 -30.64% +6.57% +37.21
FinancialModeler 96.44 8/10/2009 Underperform 5Y $22.33 -29.66% +6.93% +36.59
noescaper 86.54 7/30/2009 Underperform 3M $21.29 -26.21% +8.92% +35.13
oneisthelonelies < 20 8/6/2007 Outperform 5Y $14.15 +11.02% -21.80% +32.82
schwah8 99.66 10/13/2008 Underperform NS $17.70 -11.24% +16.34% +27.58
Grinnell4Eva 28.53 6/6/2008 Outperform 1Y $14.88 +5.58% -18.76% +24.34
giffman62 < 20 6/6/2008 Outperform NS $15.22 +3.22% -20.87% +24.09 1 Comment
Pmccorm 84.96 6/5/2008 Outperform 3Y $15.28 +2.81% -20.43% +23.25
benes27 46.28 6/5/2008 Outperform 3M $15.28 +2.81% -20.42% +23.23
kurthauer1998 86.70 1/22/2008 Underperform 5Y $24.00 -34.54% -12.23% +22.31 1 Comment
View Complete Scorecard »

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Member Name Member
Rating		 Start
Date		 Call Time
Frame		 Start
Price		 Stock
Gain		 S&P
Gain		 Score End Date Commentary
TrackThinkEquity 69.79 5/5/2009 Outperform NS $15.03 +4.52% +19.52% -15.00
TrackCreditSuiss 91.16 5/1/2009 Outperform NS $14.20 +10.63% +23.80% -13.17
TrackPiperJaff 80.38 3/30/2009 Outperform NS $14.80 +6.15% +35.64% -29.49
TrackZacks 69.52 11/6/2008 Outperform 3M $17.61 +17.55% +15.63% +1.92 9/24/2009 @ $20.70 1 Comment
TrackMerriman < 20 10/24/2008 Outperform NS $16.69 -5.87% +30.55% -36.42
TrackZacks 69.52 1/14/2008 Outperform 3M $24.54 -20.95% -30.06% +9.12 10/20/2008 @ $19.40 1 Comment
TrackEveillard 89.92 12/31/2007 Outperform NS $24.15 -20.54% -10.19% -10.35 3/31/2008 @ $19.19 1 Comment
TrackCarisandCo 78.62 12/3/2007 Outperform NS $22.30 -21.93% -11.16% -10.77 3/13/2008 @ $17.41
TrackCanaccord 84.17 11/2/2007 Outperform NS $21.19 -25.86% -25.25% -0.62
TrackIcahn 27.08 9/30/2007 Outperform NS $17.80 -11.74% -26.44% +14.70 1 Comment
TrackNeedham < 20 11/8/2006 Outperform NS $23.95 -34.41% -17.46% -16.95
TrackCreditSuiss 91.16 11/6/2006 Outperform NS $21.05 -17.77% +1.49% -19.26 6/5/2008 @ $17.31
TrackRBCCapMkts 81.74 10/19/2006 Outperform NS $19.50 -16.87% -22.85% +5.97 10/29/2009 @ $16.21
TrackLehmanBros 76.60 10/19/2006 Outperform NS $19.50 -19.44% -16.60% -2.83
TrackJimCramer < 20 8/16/2006 Underperform 3W $14.86 +5.72% -12.38% -18.10

Featured Broker Partners